參考文獻/References:
[1] 中華中醫(yī)藥學會.骨質(zhì)疏松性骨折中醫(yī)診療指南[J].中醫(yī)正骨,2023,35(1):1-9.
[2] LEWIECKI E M.Evaluating patients for secondary causes of osteoporosis[J].Curr Osteoporos Rep,2022,20(1):1-12.
[3] BELAYA Z,ROZHINSKAYA L,DEDOV I,et al.A summary of the Russian clinical guidelines on the diagnosis and treatment of osteoporosis[J].Osteoporos Int,2023,34(3):429-447.
[4] 孟迅吾,周學瀛.協(xié)和代謝性骨病學[M].北京:中國協(xié)和醫(yī)科大學出版社,2020:749.
[5] 《中國骨質(zhì)疏松雜志》骨代謝專家組.骨代謝生化指標臨床應(yīng)用專家共識(2023修訂版)[J].中國骨質(zhì)疏松雜志,2023,29(4):469-476.
[6] 張萌萌.骨代謝實驗室診斷[M].北京:化學工業(yè)出版社,2020:54-55.
[7] LI X P,LI X Y,YANG M H,et al.Changes of bone turnover markers after elderly hip fracture surgery[J].J Bone Miner Metab,2021,39(2):237-244.
[8] 中華醫(yī)學會骨質(zhì)疏松和骨礦鹽疾病分會.骨轉(zhuǎn)換生化標志物臨床應(yīng)用指南[J].中華骨質(zhì)疏松和骨礦鹽疾病雜志,2021,14(4):321-336.
[9] 張萌萌,徐又佳,侯建明,等.骨質(zhì)疏松實驗室診斷及影響因素專家共識2022[J].中國骨質(zhì)疏松雜志,2022,9(28):1249-1259.
[10] PAINTER S E,KLEEREKOPER M,CAMACHO P M.Secondary osteoporosis:a review of the recent evidence[J].EndocrPract,2006,12(4):436-445
[11] 梁玉龍,陳濤,富斌,等.不同中醫(yī)體質(zhì)體積骨密度及骨代謝指標的定量分析[J].中醫(yī)學報,2023,38(8):1758-1764.
[12] 廖文強.老年原發(fā)性骨質(zhì)疏松癥中醫(yī)證型與骨代謝指標的相關(guān)性研究[D].福州:福建中醫(yī)藥大學,2022.
[13] 張奇.原發(fā)性骨質(zhì)疏松癥患者中醫(yī)體質(zhì)類型與骨代謝指標的相關(guān)性研究[D].廣州:廣州中醫(yī)藥大學,2020.
[14] JAVAID M K,SAMIA,LEMS W,et al.A patient level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement:a position paper of the IOF Capture the Fracture Working Group,National Osteoporosis Foundation and Fragility Fracture Network[J].Osteoporos Int,2020,31(7):1193-1204.
[15] 林巧璇,劉晶,盧莉銘,等.補腎活血湯對骨質(zhì)疏松性椎體壓縮性骨折PKP術(shù)后患者疼痛和骨代謝的影響[J].中國中醫(yī)骨傷科雜志,2021,29(3):21-26.
[16] 侯偉,萬躉,張旭,等.抗骨質(zhì)疏松膠囊治療胸腰椎骨質(zhì)疏松性壓縮骨折的臨床療效觀察[J].四川中醫(yī),2023,41(6):159-162.
[17] 沈凱,尹永濤.自擬地萸生髓湯對老年骨質(zhì)疏松性椎體壓縮性骨折PKP術(shù)后患者的影響[J].醫(yī)學理論與實踐,2022,35(12):2066-2068.
[18] 蘧冰,侯欽云,張晶華.骨疏松方治療老年骨質(zhì)疏松癥臨床效果研究[J].實用醫(yī)院臨床雜志,2023,20(2):92-95.
[19] 賴明星,邢利威,趙冬,等.針灸對原發(fā)性骨質(zhì)疏松癥骨代謝影響的研究概述[J].遼寧中醫(yī)雜志,2020,47(12):207-211.
[20] HUANG R,XU S,LI D,et al.Acupoint injection treatment for primary osteoporosis:a systematic review and meta-analysis of randomized controlled trials protocol[J].Medicine,2019,98(32):e16735.
[21] 落樂,何成文,孫大連,等.手法復位對骨質(zhì)疏松癥性椎體壓縮骨折患者骨代謝水平、生化指標影響的研究[J].湖北中醫(yī)藥大學學報,2021,23(2):101-104.
[22] MLGLIORINI F,MAFFULLI N,SPIEZIA F,et al.Biomarkers as therapy monitoring for postmenopausal osteoporosis:a systematic review[J].J OrthopSurg Res,2021,16(1):318.
[23] SHIGDEL R,OSIMA M,AHMED L A,et al.Bone turnover markers are associated with higher cortical porosity,thinner cortices,and larger size of the proximal femur and non-vertebral fractures[J].Bone,2015,81:1-6.
[24] IVASKA K K, MCGUIGAN F E, MALMGREN L,et al.Bone turnover marker profiling and fracture risk in older women:fracture risk from age 75 to 90[J].Calcif Tissue Int,2022,111(3):288-299.
[25] IVASKA K K,GERDHEM P,VAANANEN H K,et al.Bone turnover markers and prediction of fracture:a prospective follow-up study of 1040 elderly women for a mean of 9 years[J].J Bone Miner Res,2010,25(2):393-403.
[26] VILACA T,GOSSIEL F,EASTELL R.Bone turnover markers:use in fracture prediction[J].J Clin Densitom,2017,20(3):346-352.
相似文獻/References:
[1]潘雄,劉其順,應(yīng)行,等.中藥聯(lián)合4步康復鍛煉法對骨質(zhì)疏松性椎體壓縮
骨折患者生存質(zhì)量的影響[J].中醫(yī)正骨,2015,27(04):65.
[2]宋永枝,陳雙玲.唑來膦酸靜脈滴注聯(lián)合鮭降鈣素肌肉注射治療
骨質(zhì)疏松性長骨骨折[J].中醫(yī)正骨,2016,28(01):70.
[3]吳鵬,王博,孔令成,等.強骨飲顆粒聯(lián)合阿侖膦酸鈉維D3片口服在原發(fā)性骨質(zhì)疏松性髖部骨折術(shù)后抗骨質(zhì)疏松治療中的應(yīng)用[J].中醫(yī)正骨,2016,28(05):16.
WU Peng,WANG Bo,KONG Lingcheng,et al.Oral application of Qiangguyin Keli(強骨飲顆粒)and alendronate sodium Vitamin D3 tablets in postoperative anti-osteoporosis treatment in patients with primary osteoporotic hip fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(12):16.
[4]陳建德,樊曉琦,夏炳江,等.球囊擴張部位對椎體后凸成形術(shù)治療骨質(zhì)疏松性椎體壓縮骨折療效及安全性的影響[J].中醫(yī)正骨,2017,29(02):11.
CHEN Jiande,FAN Xiaoqi,XIA Bingjiang,et al.Influence of balloon dilation position on curative effect and safety of percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(12):11.
[5]史曉林,王健,王博,等.脆性骨折的防治進展[J].中醫(yī)正骨,2017,29(05):20.
[6]陳勍,劉鐘,陳文亮,等.股骨近端防旋髓內(nèi)釘固定聯(lián)合口服仙靈骨葆膠囊治療腎陽虛型骨質(zhì)疏松性股骨轉(zhuǎn)子間骨折[J].中醫(yī)正骨,2017,29(07):69.
[7]曾武,林曙峰,朱俊峰,等.女性骨質(zhì)疏松性橈骨遠端骨折鎖定鋼板內(nèi)固定術(shù)后腕關(guān)節(jié)功能恢復的影響因素分析[J].中醫(yī)正骨,2017,29(08):39.
ZENG Wu,LIN Shufeng,ZHU Junfeng,et al.Analysis of factors influencing wrist function recovery after locking plate internal fixation for treatment of osteoporotic distal radius fractures in female[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(12):39.
[8]丁志清,顏峰,喻燦明,等.椎體后凸成形術(shù)后非典型骨水泥植入綜合征死亡1例[J].中醫(yī)正骨,2017,29(11):76.
[9]俞興,王婷,楊濟洲,等.經(jīng)皮椎體成形術(shù)和經(jīng)皮椎體后凸成形術(shù)治療Kmmell病的對比研究[J].中醫(yī)正骨,2018,30(06):23.
YU Xing,WANG Ting,YANG Jizhou,et al.A retrospective trial of percutaneous vertebroplasty versus percutaneous kyphoplasty for treatment of Kmmell's diseases[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(12):23.
[10]彭小東,張曉剛,趙文韜,等.有限元分析在過伸復位治療骨質(zhì)疏松性椎體壓縮性骨折生物力學研究中的應(yīng)用進展[J].中醫(yī)正骨,2018,30(07):25.